BRAF mutations in chronic lymphocytic leukemia

BRAF mutations have been shown to occur at a high frequency in melanoma and thyroid cancer, but also at lower frequencies in hematological malignancies. To assess the potential role of BRAF, we have sequenced exons 11 and 15 of BRAF in 138 cases with chronic lymphocytic leukemia (CLL) and 32 cases o...

Full description

Saved in:
Bibliographic Details
Main Authors: Jebaraj, Billy Michael Chelliah (Author) , Kienle, Dirk Lars (Author) , Bühler, Andreas (Author) , Winkler, Dirk (Author) , Döhner, Hartmut (Author) , Stilgenbauer, Stephan (Author) , Zenz, Thorsten (Author)
Format: Article (Journal)
Language:English
Published: 2013
In: Leukemia and lymphoma
Year: 2012, Volume: 54, Issue: 6, Pages: 1177-1182
ISSN:1029-2403
DOI:10.3109/10428194.2012.742525
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3109/10428194.2012.742525
Get full text
Author Notes:Billy Michael Chelliah Jebaraj, Dirk Kienle, Andreas Bühler, Dirk Winkler, Hartmut Döhner, Stephan Stilgenbauer & Thorsten Zenz

MARC

LEADER 00000caa a2200000 c 4500
001 175246334X
003 DE-627
005 20230427070819.0
007 cr uuu---uuuuu
008 210325r20132012xx |||||o 00| ||eng c
024 7 |a 10.3109/10428194.2012.742525  |2 doi 
035 |a (DE-627)175246334X 
035 |a (DE-599)KXP175246334X 
035 |a (OCoLC)1341401436 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Jebaraj, Billy Michael Chelliah  |e VerfasserIn  |0 (DE-588)1052099564  |0 (DE-627)787812528  |0 (DE-576)407847294  |4 aut 
245 1 0 |a BRAF mutations in chronic lymphocytic leukemia  |c Billy Michael Chelliah Jebaraj, Dirk Kienle, Andreas Bühler, Dirk Winkler, Hartmut Döhner, Stephan Stilgenbauer & Thorsten Zenz 
264 1 |c 2013 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 25.03.2021 
500 |a First published: 20 Nov 2012 
520 |a BRAF mutations have been shown to occur at a high frequency in melanoma and thyroid cancer, but also at lower frequencies in hematological malignancies. To assess the potential role of BRAF, we have sequenced exons 11 and 15 of BRAF in 138 cases with chronic lymphocytic leukemia (CLL) and 32 cases of B-cell prolymphocytic leukemia (B-PLL). We found an incidence of BRAF mutations of 2.8% in CLL (4/138), while no cases with B-PLL showed BRAF mutations. The analysis of a cohort of patients with fludarabine-refractory disease (n = 87) showed no increase in the mutation incidence, suggesting that this mutation is not selected for during the disease progression. A limited analysis of the effect of BRAF inhibition in primary CLL cells showed no cell death induction in CLL samples with and without BRAF mutations. Our analysis suggests that BRAF mutations occur at a low frequency in CLL. The pharmacological inhibition of MEK/ERK signaling using the mutant BRAF inhibitor PLX4720 showed no effect on viability in vitro in CLL cases. 
534 |c 2012 
650 4 |a genetic and other predisposing conditions 
650 4 |a Lymphoid leukemia 
650 4 |a pharmacotherapeutics 
700 1 |a Kienle, Dirk Lars  |d 1972-  |e VerfasserIn  |0 (DE-588)123110734  |0 (DE-627)706166329  |0 (DE-576)293560609  |4 aut 
700 1 |a Bühler, Andreas  |e VerfasserIn  |0 (DE-588)13589879X  |0 (DE-627)572485565  |0 (DE-576)282083014  |4 aut 
700 1 |a Winkler, Dirk  |d 1974-  |e VerfasserIn  |0 (DE-588)123541638  |0 (DE-627)70633907X  |0 (DE-576)293758077  |4 aut 
700 1 |a Döhner, Hartmut  |d 1957-  |e VerfasserIn  |0 (DE-588)110666585  |0 (DE-627)729880842  |0 (DE-576)375358846  |4 aut 
700 1 |a Stilgenbauer, Stephan  |d 1966-  |e VerfasserIn  |0 (DE-588)114728380  |0 (DE-627)590333151  |0 (DE-576)302364781  |4 aut 
700 1 |a Zenz, Thorsten  |d 1970-  |e VerfasserIn  |0 (DE-588)114963738  |0 (DE-627)577184202  |0 (DE-576)180278266  |4 aut 
773 0 8 |i Enthalten in  |t Leukemia and lymphoma  |d London [u.a.] : Taylor & Francis Group, 1989  |g 54(2013), 6, Seite 1177-1182  |h Online-Ressource  |w (DE-627)324746237  |w (DE-600)2030637-4  |w (DE-576)099718170  |x 1029-2403  |7 nnas  |a BRAF mutations in chronic lymphocytic leukemia 
773 1 8 |g volume:54  |g year:2013  |g number:6  |g pages:1177-1182  |g extent:6  |a BRAF mutations in chronic lymphocytic leukemia 
856 4 0 |u https://doi.org/10.3109/10428194.2012.742525  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210325 
993 |a Article 
994 |a 2013 
998 |g 114963738  |a Zenz, Thorsten  |m 114963738:Zenz, Thorsten  |p 7  |y j 
998 |g 123541638  |a Winkler, Dirk  |m 123541638:Winkler, Dirk  |p 4 
998 |g 123110734  |a Kienle, Dirk Lars  |m 123110734:Kienle, Dirk Lars  |p 2 
999 |a KXP-PPN175246334X  |e 3894442298 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 25.03.2021","First published: 20 Nov 2012"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"175246334X","language":["eng"],"person":[{"display":"Jebaraj, Billy Michael Chelliah","roleDisplay":"VerfasserIn","role":"aut","family":"Jebaraj","given":"Billy Michael Chelliah"},{"family":"Kienle","given":"Dirk Lars","display":"Kienle, Dirk Lars","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Bühler, Andreas","role":"aut","family":"Bühler","given":"Andreas"},{"display":"Winkler, Dirk","roleDisplay":"VerfasserIn","role":"aut","family":"Winkler","given":"Dirk"},{"given":"Hartmut","family":"Döhner","role":"aut","display":"Döhner, Hartmut","roleDisplay":"VerfasserIn"},{"display":"Stilgenbauer, Stephan","roleDisplay":"VerfasserIn","role":"aut","family":"Stilgenbauer","given":"Stephan"},{"family":"Zenz","given":"Thorsten","roleDisplay":"VerfasserIn","display":"Zenz, Thorsten","role":"aut"}],"title":[{"title_sort":"BRAF mutations in chronic lymphocytic leukemia","title":"BRAF mutations in chronic lymphocytic leukemia"}],"physDesc":[{"extent":"6 S."}],"relHost":[{"note":["Gesehen am 08.09.15"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"BRAF mutations in chronic lymphocytic leukemiaLeukemia and lymphoma","language":["eng"],"recId":"324746237","pubHistory":["1.1989/90 -"],"part":{"volume":"54","text":"54(2013), 6, Seite 1177-1182","extent":"6","year":"2013","issue":"6","pages":"1177-1182"},"title":[{"title_sort":"Leukemia and lymphoma","title":"Leukemia and lymphoma"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"London [u.a.] ; London [u.a.]","dateIssuedDisp":"1989-","dateIssuedKey":"1989","publisher":"Taylor & Francis Group ; Informa Healthcare"}],"id":{"issn":["1029-2403"],"eki":["324746237"],"zdb":["2030637-4"]}}],"name":{"displayForm":["Billy Michael Chelliah Jebaraj, Dirk Kienle, Andreas Bühler, Dirk Winkler, Hartmut Döhner, Stephan Stilgenbauer & Thorsten Zenz"]},"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"2013"}],"id":{"eki":["175246334X"],"doi":["10.3109/10428194.2012.742525"]}} 
SRT |a JEBARAJBILBRAFMUTATI2013